undamentalytics Newsletter
Sign in

Neonc Technologies Holdings, Inc. (NTHI) stock

Add to watchlist

Add holding +

NASDAQ: NTHI Nasdaq Biotechnology Next results ~November 12, 2026

Neonc Technologies Holdings, Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Neonc Technologies Holdings, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders5 buying, 1 selling30 purchases and 1 sale by directors and officers, last 12 monthsInsider trades
  • Funds11 adding, 12 cuttingOf 5 active managers that changed their stake, 2 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Neonc Technologies Holdings files

Where Neonc Technologies stands after its latest 10-Q

Neonc Technologies has little or no product revenue yet. It passes 1 of our 3 financial-health checks.

Our model value for Neonc Technologies Holdings is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 10, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 12, 2026 (estimated)

Current signal Operating margin compressing: TTM operating margin fell to -145637.5%, down 137032.1pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Results due soon. Results are expected around 13 November; the share price can move sharply on the day.
  • Revenue shrinking. Revenue fell 51.8% over the last 12 months.
  • Loss-making. Operating margin is -145637.5%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 137032.1 points on a year ago.
  • Heavy stock-based pay. Stock pay equals 88909.9% of revenue: a real cost that cash-flow figures leave out.
  • Volatile shares. Over the past year the shares showed annualised volatility of 112% and a beta of 1.5 against the S&P 500.

Latest results: FY2026 Q2

Filed August 10, 2026
Earnings per share
-$0.58 against an average estimate of -$0.17: missed by 248.0%
Share reaction
+24.3% in the first session after the results on August 10, 2026, against -0.3% for the S&P 500
Next report
November 12, 2026; average EPS estimate -$0.27

Neonc Technologies Holdings' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-5.8%
  • 1 week+8.9%
  • 1 month+2.7%
  • This year-62.9%
  • 1 year-68.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$39,990
Operating margin
-145637.5%
Net margin
-155404.4%
EPS (TTM, diluted)
$-2.53

Growth

Revenue growth
−51.8%

Cash

Stock pay % of revenue
88909.9%

Earnings

Last results
August 10, 2026
Next results (est.)
November 13, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Announcement
  2. Leadership
  3. Announcement
  4. Announcement
  5. Announcement
  6. Agreement
  7. Shareholder vote
  8. Announcement
  9. Announcement
  10. Results
  11. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Neonc Technologies Holdings, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

Valuation multiples over time Market data may be delayed

At fiscal year end 2025
Share price$8.27
Market value$182m
+ Net debt (− = net cash)$6m
Enterprise value$188m
Multiples
Price / sales n/m
Price / earnings —
Price / free cash flow —
EV / EBITDA —

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 12, 2026, before the open. Analysts expect revenue of $0 and EPS of −$0.27 (range −$0.47 to −$0.08) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$1.30 +59% — −100%
Next −$1.09 +16% — 0%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +43.9% on 90 days ago. In the last 30 days, 0 analysts raised Neonc Technologies Holdings, Inc.'s forecast and 1 cut it.

Consensus EPS forecast Neonc Technologies Holdings, Inc., last 90 days
−$1.50 −$1.00 −$0.50 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.91 Current fiscal year, 60 days ago: −$0.85 Current fiscal year, 30 days ago: −$1.35 Current fiscal year, 7 days ago: −$1.35 Current fiscal year, Now: −$1.30 −$1.30 Next fiscal year, 90 days ago: −$0.89 Next fiscal year, 60 days ago: −$0.75 Next fiscal year, 30 days ago: −$1.01 Next fiscal year, 7 days ago: −$1.01 Next fiscal year, Now: −$1.09 −$1.09

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.91−$0.89
60 days ago −$0.85−$0.75
30 days ago −$1.35−$1.01
7 days ago −$1.35−$1.01
Now −$1.30−$1.09

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.17 −$0.58 −248.0%
Dec 2025 −$0.37 −$0.35 +5.4%

Adjusted EPS as companies report it, against the average analyst estimate.

Analyst recommendations

4 analysts, Oct 2026
Buy4100%
Hold00%
Sell00%

Monthly trend

  1. Oct 2026134
  2. Sep 2026123
  3. Aug 2026123

Counts of recommendations published by analysts covering Neonc Technologies Holdings, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.4%
of tradable shares
Days to cover
4.73
at average volume
Short interest, 1 month
+68%
to October 15, 2026
Held by institutions
11%
of shares
Held by insiders
49.8%
of shares
Employees
5
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −68.7%

$9.80 on October 31, 2025 to $3.07

ThenNowEffect
Revenue (last 12 months) $59990 $39990 −33.3%
P/S multiple n/m n/m −44.8%
Share count 18m 22m −14.9%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 2026 to date
Return
NTHI−63%
Industry peers (median)−26%
S&P 500+11%
Months that ended higher
NTHI36%
S&P 50046%
Largest fall from a high during the year
NTHI−77%
S&P 500−9%

Worst fall since March 26, 2025: 85% from March 28, 2025 to October 8, 2026. Getting back needed a 554% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$2.53 – $11.83
From 52-week high
−74.0%
vs 50-day average
−10.9%
vs 200-day average
−43.6%
Volatility (1 year)
112%
Beta vs S&P 500
1.51

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
2 up, 3 down
typical move ±8.0%
After a week
2 up, 3 down
typical move ±23.7%
After a month
3 up, 2 down
typical move ±31.5%
Results releasedNext dayS&P 500 next day5 days21 days
August 10, 2026 +24.3% −0.3% +40.3% +3.4%
May 18, 2026 −0.4% −0.7% −6.5% −12.5%
April 3, 2026 −3.5% +0.5% −8.6% −30.4%
November 14, 2025 −11.4% −0.9% −34.7% +5.1%
August 22, 2025 +0.4% +1.1% +28.5% +105.9%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Neonc Technologies Holdings, Inc.
$20K $40K $60K $80K $100K FY24 Q4 FY25 Q1 FY25 Q2 FY25 Q3 FY25 Q4 Revenue (TTM), FY24 Q4: $83K Revenue (TTM), FY25 Q1: $80K Revenue (TTM), FY25 Q2: $60K Revenue (TTM), FY25 Q3: $60K Revenue (TTM), FY25 Q4: $40K $40K

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Revenue (TTM)
FY24 Q4 $83K
FY25 Q1 $80K
FY25 Q2 $60K
FY25 Q3 $60K
FY25 Q4 $40K
Operating margin (TTM) Neonc Technologies Holdings, Inc.
-150000% -100000% -50000% 0% FY24 Q4 FY25 Q1 FY25 Q2 FY25 Q3 FY25 Q4 Operating margin (TTM), FY24 Q4: -8605.4% Operating margin (TTM), FY25 Q1: -46870.7% Operating margin (TTM), FY25 Q2: -69878.0% Operating margin (TTM), FY25 Q3: -77775.1% Operating margin (TTM), FY25 Q4: -145637.5% -145637.5%

Source: SEC EDGAR filings. Retrieved November 1, 2026.

View chart data
Period Operating margin (TTM)
FY24 Q4 -8605.4%
FY25 Q1 -46870.7%
FY25 Q2 -69878.0%
FY25 Q3 -77775.1%
FY25 Q4 -145637.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2024 Dec 2024 2025 Dec 2025
Income
Revenue 0 0
Operating income −7 −58
Net income −12 −62
Diluted EPS −$0.69 −$3.20
Growth (year on year)
Revenue — −51.8%
Margins
Operating margin <−999% <−999%
Net margin <−999% <−999%
Free-cash-flow margin — <−999%
Cash flow
Cash from operations −4 −20
Capital spending — 1
Free cash flow — −21
Stock-based pay — 36
Free cash flow after stock pay — −56
Balance sheet
Cash 0 0
Total debt 0 6
Net debt (negative = net cash) −0 6
Diluted shares 17m 22m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 3 checks passed · June 30, 2026
What it owns · $5m
Short-term assets $4mLonger-term assets $1m
What it owes, and who funded it · $24m
Short-term liabilities $24mLonger-term liabilities $0mShareholders' equity $-19m
  • Short-term assets cover short-term liabilities $4m of assets due within a year against $24m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $4m short-term assets against $254,548 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$42m against $3m of interest.

From Neonc Technologies Holdings, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

R&D spending
9097.9%
of revenue

Competitors: side by side with peers

Closest by revenue in biotechnology
Last 12 months unless stated NTHI LYEL AIM IBIO LSTA CLDX Median
Revenue, last 12 months $39990 $27000 $95000 $100000 $100000 $158000 $55m
Revenue growth, last 12 months −51.8% −55.0% −21.5% −75.0% −90.7% −97.3% 12.2%
Revenue growth, 3-year average — −91.8% −17.3% −62.4% — −63.5% 13.7%
Revenue growth, latest quarter −100.0% −50.0% 4.0% −100.0% −100.0% −97.0% 10.2%
Gross margin — — −968.5% 59.9% 7.7% — 82.9%
Operating margin <−999% <−999% <−999% <−999% <−999% <−999% −191.1%
Operating margin, 3-year average — <−999% <−999% <−999% <−999% <−999% −363.5%
Net margin <−999% <−999% <−999% <−999% <−999% <−999% −172.8%
Cash from operations / revenue <−999% <−999% <−999% <−999% <−999% <−999% −168.8%
Free-cash-flow margin — <−999% <−999% <−999% <−999% <−999% −162.4%
Free-cash-flow margin, 3-year average — <−999% <−999% <−999% <−999% <−999% −310.0%
Stock pay / revenue >999% >999% 0.0% >999% >999% >999% 20.7%
Change in share count — — 49.8% 13.9% 5.1% 4.7% 8.2%

Median of all 185 companies we cover in biotechnology. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Who owns it

Funds buying and selling
Reported value
$14.3M
Institutions reporting
20
Shares held vs prior quarter
▲ 8.9%
Positions opened / closed
1 / 8

Top buyers and sellers, Q2 2026: 11 institutions bought and 12 sold ; the biggest buyer was Vanguard Capital Management LLC (+288K shares) and the biggest seller Hudson Bay Capital Management LP (−147K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Cinctive Capital Management LP $7.3M 1.6M 51.0% ▲ 12.8%
Vanguard Capital Management LLC $2.3M 504K 16.0% ▲ 133.7%
Bank Of America Corp $1M 224K 7.1% ▼ 4.7%
Westmount Partners, LLC $893,216 197K 6.3% ▲ 355.2%
Blackrock, Inc. $814,720 180K 5.7% ▲ 15.4%
Geode Capital Management, LLC $752,794 166K 5.3% ▲ 31.0%
Vanguard Fiduciary Trust Co $414,404 91K 2.9% ▲ 63.3%
State Street Corp $195,560 43K 1.4% 0.0%
Northern Trust Corp $162,496 36K 1.1% ▲ 54.1%
Global Retirement Partners, LLC $125,889 28K 0.9% —
Marshall Wace, LLP $98,680 22K 0.7% ▲ 73.2%
Royal Bank Of Canada $71,000 16K 0.5% ▼ 6.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Neonc Technologies Holdings, Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $1.5M 30 trades by 5 insiders, last 12 months Insider sales History → $16,800 1 trade by 1 insider · 100% under pre-set plans
Net ▲ $1.5M net buying
Insider Date Trade Shares Price Value
Heshmatpour Amir F CEO, President September 15, 2026 Buy 35,000 $3.30 $115,500
Garnett Keithly CFO September 15, 2026 Sell pre-set plan 5,000 $3.36 $16,800
Garnett Keithly CFO September 14, 2026 Buy 257 $3.89 $1,000
Chen Thomas C CEO September 14, 2026 Buy 5,242 $3.82 $20,024
Heshmatpour Amir F CEO, President September 14, 2026 Buy 15,000 $3.96 $59,400
Heshmatpour Amir F CEO, President September 11, 2026 Buy 37,000 $3.67 $135,790
Chen Thomas C CEO September 11, 2026 Buy 5,556 $3.60 $20,002
Heshmatpour Amir F CEO, President August 18, 2026 Buy 9,000 $5.54 $49,860
Chen Thomas C CEO August 18, 2026 Buy 12,757 $5.49 $70,036
Heshmatpour Amir F CEO, President August 17, 2026 Buy 3,000 $4.37 $13,110
Chen Thomas C CEO August 17, 2026 Buy 2,472 $4.04 $9,987
Chen Thomas C Chief Scientific Officer August 17, 2026 Buy 2,472 $4.04 $9,987

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 13, 2026 estimated from the company's past filing pattern, not announced

  • August 10, 2026
  • May 18, 2026
  • April 3, 2026
  • November 14, 2025
  • August 22, 2025

Recent SEC filings

Data status

When each part of this page on Neonc Technologies Holdings, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Neonc Technologies Holdings, Inc. in brief

What does Neonc Technologies Holdings, Inc. do?
Neonc Technologies Holdings, Inc. is a US-listed company in the biotechnology industry. Its financial year ends in December.
What is Neonc Technologies Holdings, Inc.'s stock ticker?
Neonc Technologies Holdings, Inc. trades under the ticker NTHI on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Neonc Technologies Holdings, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Neonc Technologies Holdings, Inc. reported revenue of $39,990, 51.8% lower than a year earlier, according to its SEC filings.
Who are Neonc Technologies Holdings, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Cinctive Capital Management LP, Vanguard Capital Management LLC and Bank Of America Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Neonc Technologies Holdings, Inc.'s market cap?
On December 31, 2025, Neonc Technologies Holdings, Inc.'s market capitalisation was about $182M and net debt of $5.9M. Market figures come from third-party market data and may be delayed.
Who are Neonc Technologies Holdings, Inc.'s competitors?
In our Biotechnology peer group, the companies closest to Neonc Technologies Holdings, Inc. are Lyell Immunopharma, Inc., AIM Immunotech Inc., Ibio, Inc., Lisata Therapeutics, Inc. and Celldex Therapeutics, Inc. The side-by-side comparison below sets their revenue, margins and growth against Neonc Technologies Holdings, Inc.'s.
Are insiders buying or selling Neonc Technologies Holdings, Inc. stock?
Over the last 12 months, Neonc Technologies Holdings, Inc.'s directors and officers reported 30 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is Neonc Technologies Holdings, Inc.'s next earnings date?
Around November 12, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Neonc Technologies Holdings, Inc. announces its own schedule.